These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 15827792)

  • 1. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery?
    Jang JY; Kim SW; Ahn YJ; Yoon YS; Choi MG; Lee KU; Han JK; Kim WH; Lee YJ; Kim SC; Han DJ; Kim YI; Choi SH; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee KB; Kim YC; Lee KS; Kim MW; Kim HJ; Kim HJ; Park YH
    Ann Surg Oncol; 2005 Feb; 12(2):124-32. PubMed ID: 15827792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe?
    Jang JY; Kim SW; Lee SE; Yang SH; Lee KU; Lee YJ; Kim SC; Han DJ; Choi DW; Choi SH; Heo JS; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee HE; Kang GH; Lee JM
    Ann Surg Oncol; 2008 Jan; 15(1):199-205. PubMed ID: 17909912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas: the differential diagnosis from benign entities.
    Kawai M; Uchiyama K; Tani M; Onishi H; Kinoshita H; Ueno M; Hama T; Yamaue H
    Arch Surg; 2004 Feb; 139(2):188-92. PubMed ID: 14769579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
    Schmidt CM; White PB; Waters JA; Yiannoutsos CT; Cummings OW; Baker M; Howard TJ; Zyromski NJ; Nakeeb A; DeWitt JM; Akisik FM; Sherman S; Pitt HA; Lillemoe KD
    Ann Surg; 2007 Oct; 246(4):644-51; discussion 651-4. PubMed ID: 17893501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic features and outcomes of intraductal papillary-mucinous tumors of the pancreas.
    Sugiura H; Kondo S; Islam HK; Ito K; Ono K; Morikawa T; Okushiba S; Katoh H
    Hepatogastroenterology; 2002; 49(43):263-7. PubMed ID: 11941971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience.
    Yang AD; Melstrom LG; Bentrem DJ; Ujiki MB; Wayne JD; Strouch M; Bell RH; Rao SM; Talamonti MS
    Surgery; 2007 Oct; 142(4):529-34; discussion 534-7. PubMed ID: 17950345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal papillary or mucinous tumors (IPMT) of the pancreas: report of a case series and review of the literature.
    Zamora C; Sahel J; Cantu DG; Heyries L; Bernard JP; Bastid C; Payan MJ; Sielezneff I; Familiari L; Sastre B; Barthet M
    Am J Gastroenterol; 2001 May; 96(5):1441-7. PubMed ID: 11374680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
    Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
    Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
    Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
    Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas.
    Sugiyama M; Izumisato Y; Abe N; Masaki T; Mori T; Atomi Y
    Br J Surg; 2003 Oct; 90(10):1244-9. PubMed ID: 14515294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
    Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
    Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of molecular biological factors in intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Tanaka M; Manabe T
    Scand J Gastroenterol; 2004 Nov; 39(11):1159-65. PubMed ID: 15545177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
    Pancreas; 2006 Apr; 32(3):281-7. PubMed ID: 16628084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anatomy of the head of the pancreas and various limited resection procedures for intraductal papillary-mucinous tumors of the pancreas].
    Kimura W
    Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):460-70. PubMed ID: 12854493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and prognosis of intraductal papillary mucinous neoplasms of pancreas: analysis of 38 cases].
    Lou WH; Wang DS; Ji Y; Xu XF; Kuang TT; Ni XL; Wu WC; Jin DY
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):947-50. PubMed ID: 16759531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas.
    Cuillerier E; Cellier C; Palazzo L; Devière J; Wind P; Rickaert F; Cugnenc PH; Cremer M; Barbier JP
    Am J Gastroenterol; 2000 Feb; 95(2):441-5. PubMed ID: 10685747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
    J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery.
    Akita H; Takeda Y; Hoshino H; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Mori M; Doki Y; Nagano H
    Am J Surg; 2011 Aug; 202(2):214-9. PubMed ID: 21376305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
    Schnelldorfer T; Sarr MG; Nagorney DM; Zhang L; Smyrk TC; Qin R; Chari ST; Farnell MB
    Arch Surg; 2008 Jul; 143(7):639-46; discussion 646. PubMed ID: 18645105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.